The fourth annual Cures4Cats Day will be commemorated on Saturday, October 17, 2020. Our end of the year campaign theme will recognize the significance of diabetes mellitus in cats.
Diabetes is a common and growing malady affecting cats much like their cat loving humans. Approximately one in every 230 cats will develop diabetes during their lifetime and this is expected to increase by 18% over the next ten-years. A dynamic disease that changes over time, diabetes mellitus can be complex and potentially expensive to treat. Plus, again like humans, treatment may not be effective without consistent monitoring and timely application of diet, pharmaceutical and lifestyle solutions.
Download our Cat Health article on Diabetes Mellitus
EDUCATE * ENGAGE * ENCOURAGE
This Cures4Cats campaign will aim to educate, engage, and encourage our donors and partners to help more than ever to find better and more effective treatments for this disease. Many cat lovers do not know that their cat companion has diabetes mellitus. The promotion will begin on Cures4Cats Day, October 17th, 2020 and will continue through December 31, 2020. Raising funds for further research will enable improvements in diabetic cats’ longevity and quality of life.
Please go to our website to learn more about Cures4Cats and Winn Feline Foundation. Or, if you want to help immediately, follow the “paws” to our giving page and open your heart to help with Feline Diabetes.
Prior health studies about feline diabetes funded by Winn can be reviewed in our searchable grant history page under the research tab. Two recent grants related to diabetes in cats are:
MT19-010: Stefanie DeMonaco, Virginia Polytech, “Evaluation of flash glucose monitoring systems in diabetic cats”, $15,333
While measuring blood glucose in cats at home is an effective method of monitoring their treatment, it can be difficult. This study evaluates whether a flash glucose monitoring system or sensor (FGMS) attached to the cat’s skin is as accurate and easier to use.
W20-020: Jessica Forin, Michigan State University, In Vitro Characterization of Small Molecule Inhibitors of Pancreatic Amyloidosis for Diabetic Cats, $24,365
Plaque formations (amyloid deposits) in the pancreas contribute to the occurrence of diabetes in cats. This study further characterizes the properties of a recently discovered small molecule (JF) that may inhibit the early formation of these plaques and improve the management of diabetes in cats.